Odyssean LLC’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.36M Buy
74,737
+20,558
+38% +$1.21M 0.5% 34
2026
Q2
$3.04M Buy
54,179
+21,401
+65% +$1.11M 0.49% 51
2026
Q1
$1.57M Buy
32,778
+13,831
+73% +$606K 0.57% 7
2025
Q4
$732K Buy
+18,947
New +$723K 0.53% 103

Other funds holding RPRX

Odyssean LLC's RPRX Position: Q3 2026 in Review

Odyssean LLC increased its Royalty Pharma (RPRX) stake by 38% in Q3 2026, buying an estimated $1.21M and bringing the position to 74,737 shares worth $4.36M. The position accounts for 0.5% of the portfolio, ranked #34.

Odyssean LLC first reported a position in RPRX in Q4 2025 and has held it in 4 quarters since. 707 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • Odyssean LLC held 74,737 shares of Royalty Pharma worth $4.36M as of Q3 2026.
  • Odyssean LLC bought 20,558 Royalty Pharma shares in Q3 2026, an estimated $1.21M.
  • Royalty Pharma made up 0.5% of Odyssean LLC's portfolio in Q3 2026, its #34 holding.
  • Odyssean LLC first reported a position in Royalty Pharma in Q4 2025 and has held it in 4 quarters since.
  • 707 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on Odyssean LLC's 13F filing for Q3 2026, filed 16 Nov 2026.